The effects of the thiolation with thioglycolic acid and l-cysteine on the mucoadhesion properties of the starch-graft-poly(acrylic acid)

[Display omitted] •(WS-g-PAA)gc was first thiolated using TGA and CyS, and characterized.•Thiolation of (WS-g-PAA)gc with TGA and CyS increased mucoadhesion.•(WS-g-PAA)gc-TGA conjugate has not contain free SH groups in its structure.•Thioester and thioether bonds in (WS-g-PAA)gc-TGA significantly in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Carbohydrate polymers 2017-05, Vol.163, p.129-136
Hauptverfasser: Gök, M. Koray, Demir, Kamber, Cevher, Erdal, Özsoy, Yıldız, Cirit, Ümüt, Bacınoğlu, Süleyman, Özgümüş, Saadet, Pabuccuoğlu, Serhat
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[Display omitted] •(WS-g-PAA)gc was first thiolated using TGA and CyS, and characterized.•Thiolation of (WS-g-PAA)gc with TGA and CyS increased mucoadhesion.•(WS-g-PAA)gc-TGA conjugate has not contain free SH groups in its structure.•Thioester and thioether bonds in (WS-g-PAA)gc-TGA significantly increased MDF value.•(WS-g-PAA)gc-TGA provides single use for long term vaginal application. The aim of this study is to investigate the effects of the thiolation on the mucoadhesion characteristics of the gelatinized and crosslinked wheat starch-graft-poly(acrylic acid) [(WS-g-PAA)gc] for potential use in drug delivery via vaginal route. Thiolation of (WS-g-PAA)gc was first time realized using l-cysteine hydrochloride monohydrate (CyS) and thioglycolic acid (TGA). These conjugates [(WS-g-PAA)gcth] were characterized using FTIR. The free SH group, mucoadhesion, cytotoxicity characteristics and the mechanism of the thiolation were also evaluated. To obtain fundamental data for possible application such as drug carrier, in vitro and in vivo progesterone release profiles from the mucoadhesive tablet formulations were also determined. The results showed that, vaginal tablet containing (WS-g-PAA)gc-TGA, which has not contain free SH groups in its structure, displays higher mucoadhesion than (WS-g-PAA)gc and (WS-g-PAA)gc-CyS. This tablet formulation can also be used as a drug carrier in vaginal applications.
ISSN:0144-8617
1879-1344
DOI:10.1016/j.carbpol.2017.01.065